ABOUT THIS PROGRAM

Creating Novel Ideas in Health Care

Although there has been significant and large production of medical evidence in the past two decades, only a small fraction of research evidence has genuinely translated into viable products to the public. Also, clinicians often have great ideas to improve outcomes in healthcare, but their ideas never get tested. This program aims to address these critical gaps as to inspire participants to consider this challenging but rewarding pathway to becoming an entrepreneur in healthcare. This program will introduce the process of translation from academic research to treatments and products that may go to the market. In this process, we will discuss the main principles that include rigorous scientific testing, leading to business model strategies. The goal of this program is to inspire participants to optimize their ideas and projects, providing a framework that participants can use to design a blueprint to test and turn their ideas into products in healthcare. The program will promote active discussions between researchers, academic societies, industry partners, investors, and regulatory agencies to enhance learning in this critical field.

​

During the program, participants will develop an idea and plans for testing and the initial business plan for that idea. At the end of the program, participants will pitch this idea to the program faculty and invited leading experts in the industry as a real potential idea to be commercialized. The ultimate goal of this program is to get participants to understand the pathway for commercializing science and high technology truly.

PROGRAM FACULTY

Besides the faculty involved in the creation of the program who have extensive experience in how to design robust clinical trials to validate an idea, this program will also have invited speakers with extensive industry experience in this area of innovation in health care.

FELIPE FREGNI, MD, PHD, MPH, MED

Program co-founder and co-director

Prof, Fregni is a world-renowned scientist in the area of developing and testing novel medical devices to enhance neuroplasticity. He has more than 500 peer-reviewed published articles and currently is a Professor of PMR at Harvard Medical School and directs a large neuroscience laboratory at Spaulding Rehabilitation Hospital. One of his aims is to inspire future scientists to develop novel treatments that are cost-effective in Medicine.

TIAGO LAZZARETTI, MD, PHD, MSC

Program co-founder and co-director

Dr. Tiago Lazzaretti Fernandes is a Collaborative Professor and orthopedic surgeon at the Sports Medicine Division at the University of São Paulo Medical School. He co-coordinates the Regenerative Tissue Engineering Core at Sírio-Libanês Hospital and seeks to develop these new technologies for clinical practice. Dr. Lazzaretti has finished his post-doctorate program with a research fellowship from Harvard Medical School and did his doctorate with a fellowship from Massachusetts General Hospital, Harvard Medical School. He collaborates with Spalding Rehabilitation Hospital and is a site director of Harvard T.H. Chan School of Public Health - ECPE - Principles and Practice of Clinical Research Program (PPCR).

MARCEL SIMIS, MD, MSC, PHD

Neuroscience Innovation Leader

Dr. Marcel Simis is a Neurologist and Neurophysiologist. As a neuroscientist, his research focus is on neuroplasticity and biomarkers. He works as a research collaborator at Spaulding Neuromodulation Center, Spaulding Rehabilitation Hospital – Massachusetts General Hospital. Besides, he is the chief of the Neuromodulation laboratory at the Physical and Rehabilitation Medicine Institute of the University of São Paulo. Part of his goal in innovation is to help researchers develop relevant knowledge and translational skills to clinical practice.

R$ 600.00 (BRAZILIAN REAIS)

Main Program Tuition

Tuition for registration after Sept 15, 2020

SUPPORT